tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

China Pharma Holdings Inc

CPHI
Add to Watchlist
1.110USD
-0.180-13.85%
Close 07-31 16:00（ET）Quotes delayed by 15 min
17.23MMarket Cap
0.68P/E TTM

China Pharma Holdings Inc

1.110
-0.180-13.85%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CPHI Financials

See China Pharma Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

China Pharma Holdings Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.04/--
Revenue / Forecast
983.54K/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
4.14M
-8.49%
EPS(YoY)
-0.74
72.61%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
98.15%-0.04
65.93%-0.18
73.97%-0.17
81.84%-0.16
-230.90%-2.41
68.65%-0.53
78.05%-0.65
70.17%-0.89
75.30%-0.73
82.76%-1.69
---2.94
---2.99
---2.95
---9.82
----
----
----
----
----
----
Revenue
-13.44%983.54K
8.11%1.23M
-31.26%756.22K
10.90%1.03M
-17.05%1.14M
-47.25%1.13M
-39.00%1.10M
-15.75%924.94K
-30.12%1.37M
-26.41%2.15M
-8.26%1.80M
-31.94%1.10M
22.21%1.96M
1.09%2.92M
-0.64%1.97M
-33.22%1.61M
-31.99%1.60M
-1.42%2.89M
-17.58%1.98M
-35.94%2.42M
Net Profit
-45.52%-1.14M
0.19%-1.22M
41.72%-651.48K
63.26%-528.37K
17.82%-785.57K
0.63%-1.22M
-43.76%-1.12M
-142.51%-1.44M
-100.83%-955.89K
2.53%-1.23M
1.67%-777.60K
33.25%-593.03K
53.77%-475.98K
-28.90%-1.26M
4.34%-790.77K
-7.72%-888.39K
-34.17%-1.03M
18.88%-980.72K
18.14%-826.67K
-6418.56%-824.76K
Net Margin
-68.12%-116.23%
7.68%-99.68%
15.22%-86.15%
66.87%-51.51%
0.93%-69.14%
-88.37%-107.98%
-135.67%-101.61%
-187.84%-155.48%
-187.39%-69.78%
-32.44%-57.32%
---43.12%
---54.02%
---24.28%
---43.28%
----
----
----
----
----
----
Gross Margin
342.41%29.03%
186.84%12.30%
83.30%-7.89%
92.27%-8.48%
43.44%-11.97%
-284.58%-14.16%
-265.30%-47.23%
-721.77%-109.78%
-333.27%-21.17%
-352.00%-3.68%
---12.93%
---13.36%
--9.08%
--1.46%
----
----
----
----
----
----
Debt to assets ratio
-69.33%7.52%
-53.86%11.01%
-27.34%21.32%
-10.80%24.89%
-2.37%24.52%
-13.01%23.86%
-14.35%29.34%
-42.64%27.90%
-49.48%25.12%
-44.05%27.42%
--34.26%
--48.63%
--49.73%
--49.01%
----
----
----
----
----
----
Income Statement
Revenue
-13.44%983.54K
8.11%1.23M
-31.26%756.22K
10.90%1.03M
-17.05%1.14M
-47.25%1.13M
-39.00%1.10M
-15.75%924.94K
-30.12%1.37M
-26.41%2.15M
-8.26%1.80M
-31.94%1.10M
22.21%1.96M
1.09%2.92M
-0.64%1.97M
-33.22%1.61M
-31.99%1.60M
-1.42%2.89M
-17.58%1.98M
-35.94%2.42M
Operating profit
-47.28%-1.12M
-0.35%-1.20M
42.12%-628.14K
53.14%-652.12K
17.19%-758.62K
-0.97%-1.20M
-52.09%-1.09M
-204.95%-1.39M
-130.47%-916.05K
-1.32%-1.18M
-3.61%-713.54K
41.47%-456.31K
56.40%-397.48K
-80.21%-1.17M
9.67%-688.65K
-3.54%-779.59K
-30.91%-911.72K
41.11%-648.69K
19.96%-762.40K
-1104.13%-752.95K
Net Profit
-45.52%-1.14M
0.19%-1.22M
41.72%-651.48K
63.26%-528.37K
17.82%-785.57K
0.63%-1.22M
-43.76%-1.12M
-142.51%-1.44M
-100.83%-955.89K
2.53%-1.23M
1.67%-777.60K
33.25%-593.03K
53.77%-475.98K
-28.90%-1.26M
4.34%-790.77K
-7.72%-888.39K
-34.17%-1.03M
18.88%-980.72K
18.14%-826.67K
-6418.56%-824.76K
Balance Sheet
Current assets
-29.72%2.00M
-28.25%2.35M
-37.70%2.33M
-32.02%2.70M
-44.37%2.85M
-45.47%3.27M
-35.62%3.74M
-28.12%3.97M
-15.73%5.12M
0.54%6.00M
3.59%5.81M
-11.70%5.53M
-25.53%6.08M
-34.41%5.96M
35.36%5.61M
18.92%6.26M
67.22%8.17M
70.87%9.09M
-17.73%4.14M
-27.48%5.26M
Total current liabilities
41.89%7.27M
47.50%7.40M
39.13%6.62M
11.43%5.25M
-10.58%5.12M
-26.44%5.02M
-32.55%4.76M
-55.32%4.71M
-51.95%5.73M
-46.46%6.82M
-44.11%7.06M
26.15%10.55M
20.39%11.92M
21.17%12.74M
20.81%12.63M
-31.44%8.36M
-10.22%9.90M
-7.81%10.51M
-9.53%10.45M
7.54%12.19M
Total assets
217.53%45.14M
108.22%31.00M
17.37%15.80M
-3.47%13.77M
-12.19%14.22M
-9.60%14.89M
-12.29%13.47M
-9.19%14.26M
-6.72%16.19M
-7.39%16.47M
-5.25%15.35M
-12.36%15.70M
-17.52%17.36M
-21.48%17.78M
-10.89%16.20M
-10.16%17.92M
6.02%21.04M
7.25%22.65M
-13.92%18.18M
-13.90%19.94M
Total liabilities
12.04%8.12M
15.69%8.26M
7.98%7.49M
6.60%7.30M
-8.24%7.25M
-20.80%7.14M
-24.93%6.94M
-39.63%6.85M
-37.74%7.90M
-33.20%9.01M
-30.87%9.24M
-18.30%11.35M
-19.21%12.69M
-18.87%13.49M
18.01%13.37M
3.53%13.89M
23.83%15.70M
26.83%16.63M
-14.60%11.33M
-9.12%13.42M
Total equity
431.21%37.02M
193.50%22.74M
27.35%8.31M
-12.78%6.46M
-15.95%6.97M
3.93%7.75M
6.83%6.53M
70.21%7.41M
77.59%8.29M
73.77%7.45M
115.56%6.11M
8.15%4.35M
-12.56%4.67M
-28.71%4.29M
-58.64%2.83M
-38.31%4.02M
-25.48%5.34M
-24.82%6.02M
-12.78%6.85M
-22.31%6.52M
Cash Flow Statement
Net operating income
4.38%-55.29K
-36.27%151.99K
-404.74%-236.99K
500.24%291.08K
90.12%-57.82K
1168.29%238.47K
-104.66%-46.95K
66.40%-72.73K
60.14%-585.16K
-103.82%-22.32K
359.69%1.01M
35.16%-216.44K
-66.95%-1.47M
395.08%584.59K
148.60%219.12K
-149.38%-333.82K
-217.58%-879.44K
-159.16%-198.11K
-100.92%-450.85K
639.52%676.04K
Net investment
----
97.89%-5.77K
-540.33%-40.60K
64.68%-9.92K
---80.97K
-5927.21%-272.85K
113.67%9.22K
-723.99%-28.09K
-100.00%0.00
-116.60%-4.53K
73.29%-67.45K
102.57%4.50K
4123.29%55.96K
486.45%27.27K
39.29%-252.55K
-1066.90%-175.29K
---1.39K
-103.03%-7.06K
-60.34%-415.98K
96.95%-15.02K
Net financing
-13.27%-79.33K
-1167.22%-72.59K
-1885.97%-122.21K
-525.98%-29.19K
-1121.48%-70.03K
-77.61%6.80K
101.44%6.84K
633.62%6.85K
-98.68%6.86K
104.52%30.38K
-1778.13%-476.40K
100.11%934.00
287.92%518.24K
-114.55%-672.06K
106.68%28.39K
-255.20%-850.55K
-89.98%-275.78K
45928.53%4.62M
65.55%-425.12K
-72.25%548.05K

FAQs

What is the total revenue of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its total revenue reached 4.14M, with a year-on-year change of 4.53M.

What are the current assets of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its current assets were 2.35M, with a year-on-year change of -28.25.

What are the total assets of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its total assets of China Pharma Holdings Inc were 31.00M, with a year-on-year change of 108.22.

What are the total liabilities of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its total liabilities of China Pharma Holdings Inc were 8.26M, with a year-on-year change of 15.69.

What is the total equity of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its total equity of China Pharma Holdings Inc was 22.74M, with a year-on-year change of 193.50.

What is the net operating income of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its net operating income of China Pharma Holdings Inc was -3.24M, with a year-on-year change of 29.41.

What is the net investment of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its net investment of China Pharma Holdings Inc was -137.25K, with a year-on-year change of 52.95.

What is the net financing of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its net financing of China Pharma Holdings Inc was -294.03K, with a year-on-year change of -1174.94.

What is the Earnings Per Share (EPS) of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.74, with a year-on-year change of 72.61.

What is the net income of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its net income was -3.19M, with a year-on-year change of 32.70.

What is the net margin of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its net profit margin was -76.91, with a year-on-year change of 26.45.

What is the gross margin of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its gross margin was -3.18, with a year-on-year change of 92.74.

What is the debt-to-asset ratio of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 11.01, with a year-on-year change of -53.86.

What is the Return on Equity (ROE) of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its Return on Equity (ROE) was -20.91, with a year-on-year change of 66.44.

What is the Return on Assets (ROA) of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -13.89, with a year-on-year change of 54.01.

What is the operating profit of China Pharma Holdings Inc?

According to China Pharma Holdings Inc's FY2025 earnings report, its operating profit was -3.24M, with a year-on-year change of 29.41.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy